Role of T cells in the pathogenesis of mucous membrane pemphigoid

References

• Bagan J, Muzio L, Scully C. Number III Mucous membrane pemphigoid. Oral Dis. 11(4), 197–218 (2005).
   PubMedGoogle Scholar
• Li K, Guidice GJ, Tamai K et al. Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone. J. Invest. Dermatol. 99(3), 258–263 (1992).
   PubMedGoogle Scholar
• Balding SD, Prost C, Diaz LA et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J. Invest. Dermatol. 106(1), 141–146 (1996).
   PubMedGoogle Scholar
• Schumann H, Baetge J, Tasanen K et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am. J. Pathol. 156(2), 685–695 (2000).
   PubMed Web of Science ®Google Scholar
• Leverkus M, Bhol K, Hirako Y et al. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br. J. Dermatol. 145(6), 998–1004 (2001).
   PubMedGoogle Scholar
• Schmidt E, Skrobek C, Kromminga A et al. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br. J. Dermatol. 145(5), 778–783 (2001).
   PubMed Web of Science ®Google Scholar
• Kromminga A, Sitaru C, Meyer J et al. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. J. Dermatol. Sci. 28(1), 68–75 (2002).
   PubMedGoogle Scholar
• Bhol KC, Goss L, Kumari S, Colon JE, Ahmed AR. Autoantibodies to human α6 integrin in patients with oral pemphigoid. J. Dent. Res. 80(8), 1711–1715 (2001).
   PubMed Web of Science ®Google Scholar
• Lazarova Z, Hsu R, Yee C, Yancey KB. Anti-epiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (α3β3γ). Br. J. Dermatol. 139(5), 791–797 (1998).
   PubMedGoogle Scholar
• Chan LS, Ahmed AR, Anhalt GJ et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch. Dermatol. 138(3), 370–379 (2002).
   PubMed Web of Science ®Google Scholar
• Bedane C, Prost C, Bernard P et al. Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy. J. Invest. Dermatol. 97(1), 3–9 (1991).
   PubMedGoogle Scholar
• Bernard P, Prost C, Aucouturier P et al. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J. Invest. Dermatol. 97(2), 259–263 (1991).
   PubMed Web of Science ®Google Scholar
• Setterfield J, Shirlaw PJ, Kerr-Muir M et al. Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br. J. Dermatol. 138(4), 602–610 (1998).
   PubMedGoogle Scholar
• Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB. Passive transfer of antilaminin 5 antibodies induces subepidermal blisters in neonatal mice. J. Clin. Invest. 98(7), 1509–1518 (1996).
   PubMed Web of Science ®Google Scholar
• Chan RY, Bhol K, Tesavibul N et al. The role of antibody to human β4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest. Ophthalmol. Vis. Sci. 40(10), 2283–2290 (1999).
   PubMed Web of Science ®Google Scholar
• Colon JE, Bhol KC, Razzaque MS, Ahmed AR. In vitro organ culture model for mucous membrane pemphigoid. Clin. Immunol. 98(2), 229–234 (2001).
   PubMedGoogle Scholar
• Schmidt E, Reimer S, Kruse N et al. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J. Invest. Dermatol. 115(5), 842–848 (2000).
   PubMed Web of Science ®Google Scholar
• Schmidt E, Wehr B, Tabengwa EM et al. Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes. Clin. Exp. Immunol. 135(3), 497–504 (2004).
   PubMed Web of Science ®Google Scholar
• Liu Z, Giudice GJ, Swartz SJ et al. The role of complement in experimental bullous pemphigoid. J. Clin. Invest. 95(4), 1539–1544 (1995).
   PubMed Web of Science ®Google Scholar
• Liu Z, Giudice GJ, Zhou X et al. A major role for neutrophils in experimental bullous pemphigoid. J. Clin. Invest. 100(5), 1256–1263 (1997).
   PubMed Web of Science ®Google Scholar
• Liu Z, Shipley JM, Vu TH et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188(3), 475–482 (1998).
   PubMed Web of Science ®Google Scholar
• Liu Z, Shapiro SD, Zhou X et al. A critical role for neutrophil elastase in experimental bullous pemphigoid. J. Clin. Invest. 105(1), 113–123 (2000).
   PubMed Web of Science ®Google Scholar
• Gammon WR, Merritt CC, Lewis DM et al. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J. Invest. Dermatol. 78(4), 285–290 (1982).
   PubMed Web of Science ®Google Scholar
• Bernauer W, Wright P, Dart JK, Leonard JN, Lightman S. Cytokines in the conjunctiva of acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis. Graefes Arch. Clin. Exp. Ophthalmol. 231(10), 563–570. (1993).
   PubMedGoogle Scholar
• Elder MJ, Lightman S. The immunological features and pathophysiology of ocular cicatricial pemphigoid. Eye 8(2), 196–199. (1994).
   PubMed Web of Science ®Google Scholar
• Czech W, Schaller J, Schopf E, Kapp A. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J. Am. Acad. Dermatol. 29(2 Pt 1), 210–215 (1993).
   PubMed Web of Science ®Google Scholar
• Borrego L, Maynard B, Peterson EA et al. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am. J. Pathol. 148(3), 897–909 (1996).
   PubMed Web of Science ®Google Scholar
• Delgado JC, Turbay D, Yunis EJ et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc. Natl Acad. Sci. USA 93(16), 8569–8571 (1996).
   PubMedGoogle Scholar
• Yunis JJ, Mobini N, Yunis EJ et al. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc. Natl Acad. Sci. USA 91(16), 7747–7751 (1994).
   PubMedGoogle Scholar
• Setterfield J, Theron J, Vaughan RW et al. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br. J. Dermatol. 145(3), 406–414 (2001).
   PubMed Web of Science ®Google Scholar
• Bernard A, Coitot S, Bremont A, Bernard G. T and B-cell co-operation: a dance of life and death. Transplantation 79(Suppl. 3), S8–S11 (2005).
   Google Scholar
• Datta SK, Zhang L, Xu L. T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens. J. Mol. Med. 83(4), 267–278 (2005).
   PubMedGoogle Scholar
• Goodnow CC, Sprent J, de St Groth BF, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435(7042), 590–597 (2005).
   PubMed Web of Science ®Google Scholar
• Aho S, Uitto J. 180-kD bullous pemphigoid antigen/type XVII collagen: tissue-specific expression and molecular interactions with keratin 18. J. Cell Biochem. 72(3), 356–367 (1999).
   PubMedGoogle Scholar
• Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T-cells control autoimmunity? Curr. Opin. Immunol. 17(6), 638–642 (2005).
   PubMed Web of Science ®Google Scholar
• Teraki Y, Hotta T, Shiohara T. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. J. Invest. Dermatol. 117(5), 1097–1102 (2001).
   PubMed Web of Science ®Google Scholar
• Gombert M, Dieu-Nosjean MC, Winterberg F et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T-cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 174(8), 5082–5091 (2005).
   PubMed Web of Science ®Google Scholar
• Black AP, Seneviratne SL, Jones L et al. Rapid effector function of circulating NC16A-specific T-cells in individuals with mucous membrane pemphigoid. Br. J. Dermatol. 151(6), 1160–1164 (2004).
   PubMedGoogle Scholar
• Caproni M, Calzolari A, Salvatore E et al. Cytokine profile and supposed contribution to scarring in cicatricial pemphigoid. J. Oral Pathol. Med. 32(1), 34–40 (2003).
   PubMedGoogle Scholar
• Eming R, Budinger L, Riechers R et al. Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay. Br. J. Dermatol. 143(6), 1279–1282 (2000).
   PubMed Web of Science ®Google Scholar
• Budinger L, Borradori L, Yee C et al. Identification and characterization of autoreactive T-cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J. Clin. Invest. 102(12), 2082–2089 (1998).
   PubMed Web of Science ®Google Scholar
• Lin MS, Fu CL, Giudice GJ et al. Epitopes targeted by bullous pemphigoid T-lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J. Invest. Dermatol. 115(6), 955–961 (2000).
   PubMed Web of Science ®Google Scholar
• Hacker-Foegen MK, Zillikens D, Giudice GJ, Lin MS. T-cell receptor gene usage of BP180-specific T-lymphocytes from patients with bullous pemphigoid and pemphigoid gestationis. Clin. Immunol. 113(2), 179–186 (2004).
   PubMed Web of Science ®Google Scholar
• Rico MJ, Streilein RD, Hall RP III. Peripheral blood mononuclear cells from patients with bullous pemphigoid have an increased frequency of response to synthetic peptides encoded by BPAG1. J. Invest. Dermatol. 103(1), 73–77 (1994).
   PubMedGoogle Scholar